Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Fujiwara

Showing results (61-70 of 121) with videos related to

Pageof 13
Sort By:
Transfusion|December 30, 2015
Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulinHideaki Fujiwara, Yoshinobu Maeda, Yasuhisa Sando, et al.
Blood Cell Therapy|December 10, 2025
Feasibility of early tacrolimus initiation in haploidentical-PBSCT with post-transplant cyclophosphamide after melphalan-based conditioning regimenWataru Kitamura, Toshiki Terao, Ken-Ichi Matsuoka, et al.
Internal Medicine (Tokyo, Japan)|June 30, 2024
Activated CD4<sup>+</sup> T Cell Proportion in the Peripheral Blood Correlates with the Duration of Cytokine Release Syndrome and Predicts Clinical Outcome after Chimeric Antigen Receptor T Cell TherapyWataru Kitamura, Noboru Asada, Shuntaro Ikegawa, et al.
Acta Medica Okayama|December 24, 2025
Recurrence of FVIII Inhibitor during Surgery in a Patient with Severe Hemophilia A Receiving Emicizumab ProphylaxisMoe Hagihara, Keisuke Seike, Kenta Hayashino, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 16, 2022
Successful neutrophil engraftment supported by granulocyte transfusion in adult allogeneic transplant patients with peri-transplant active infectionShuntaro Ikegawa, Nobuharu Fujii, Keiko Fujii, et al.
International Journal of Hematology|June 9, 2025
Therapeutic impact of mesenchymal stem cells on idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantationChihiro Kamoi, Toshiki Terao, Yui Kambara, et al.
International Journal of Hematology|December 23, 2022
Association between early corticosteroid administration and long-term survival in non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantationYui Kambara, Nobuharu Fujii, Yoshiaki Usui, et al.
Ejhaem|August 19, 2024
Combination of reduced post-transplant cyclophosphamide and early tacrolimus initiation increases the incidence of chronic graft-versus-host disease in human leukocyte antigen-haploidentical peripheral blood stem-cell transplantationToshiki Terao, Takumi Kondo, Makoto Nakamura, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 2014
Programmed death-1 pathway in host tissues ameliorates Th17/Th1-mediated experimental chronic graft-versus-host diseaseHideaki Fujiwara, Yoshinobu Maeda, Koichiro Kobayashi, et al.
British Journal of Haematology|March 9, 2023
Bone marrow microenvironment disruption and sustained inflammation with prolonged haematologic toxicity after CAR T-cell therapyWataru Kitamura, Noboru Asada, Yusuke Naoi, et al.
Pageof 13

Showing results (61-70 of 121) with videos related to

Sort By:
Pageof 13
Transfusion|December 30, 2015
Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulinHideaki Fujiwara, Yoshinobu Maeda, Yasuhisa Sando, et al.
Blood Cell Therapy|December 10, 2025
Feasibility of early tacrolimus initiation in haploidentical-PBSCT with post-transplant cyclophosphamide after melphalan-based conditioning regimenWataru Kitamura, Toshiki Terao, Ken-Ichi Matsuoka, et al.
Internal Medicine (Tokyo, Japan)|June 30, 2024
Activated CD4<sup>+</sup> T Cell Proportion in the Peripheral Blood Correlates with the Duration of Cytokine Release Syndrome and Predicts Clinical Outcome after Chimeric Antigen Receptor T Cell TherapyWataru Kitamura, Noboru Asada, Shuntaro Ikegawa, et al.
Acta Medica Okayama|December 24, 2025
Recurrence of FVIII Inhibitor during Surgery in a Patient with Severe Hemophilia A Receiving Emicizumab ProphylaxisMoe Hagihara, Keisuke Seike, Kenta Hayashino, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 16, 2022
Successful neutrophil engraftment supported by granulocyte transfusion in adult allogeneic transplant patients with peri-transplant active infectionShuntaro Ikegawa, Nobuharu Fujii, Keiko Fujii, et al.
International Journal of Hematology|June 9, 2025
Therapeutic impact of mesenchymal stem cells on idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantationChihiro Kamoi, Toshiki Terao, Yui Kambara, et al.
International Journal of Hematology|December 23, 2022
Association between early corticosteroid administration and long-term survival in non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantationYui Kambara, Nobuharu Fujii, Yoshiaki Usui, et al.
Ejhaem|August 19, 2024
Combination of reduced post-transplant cyclophosphamide and early tacrolimus initiation increases the incidence of chronic graft-versus-host disease in human leukocyte antigen-haploidentical peripheral blood stem-cell transplantationToshiki Terao, Takumi Kondo, Makoto Nakamura, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 2014
Programmed death-1 pathway in host tissues ameliorates Th17/Th1-mediated experimental chronic graft-versus-host diseaseHideaki Fujiwara, Yoshinobu Maeda, Koichiro Kobayashi, et al.
British Journal of Haematology|March 9, 2023
Bone marrow microenvironment disruption and sustained inflammation with prolonged haematologic toxicity after CAR T-cell therapyWataru Kitamura, Noboru Asada, Yusuke Naoi, et al.
Pageof 13